Subtype
Malignant Bone Neoplasm
CI-CAN-00001109Explore in graph →
38 active trials4 approved drugs8 evidence items
- NCIt
- C4016
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001109Explore in graph →
Clinical trials
152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (18)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05515068 | Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas(COSS-Registry) | not yet recruiting | — | 1,000 | Klinikum StuttgartOTHER | 0 | Aug 25, 2022 | clinicaltrials |
| NCT03905174 | Massive Implants the Next Generation(MING) | unknown | N/A | 30 | Iva HauptmannovaOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05397522 | The Effects of Observer Presence and Type on Patients' Perception of Exercise After Bone Tumor Resection-A Qualitative Study | unknown | N/A | 30 | Istanbul Medeniyet UniversityOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT02821507 | Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | completed | Phase 2 | 70 | Leiden University Medical CenterOTHER | 2 | Apr 20, 2022 | clinicaltrials |
| NCT02323295 | Effect of High Doses of Radiation on Bone Structure and Metabolism | completed | N/A | 12 | Massachusetts General HospitalOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT05116800 | Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma | withdrawn | Phase 2 | 0 | Brown UniversityOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT03284320 | Retrospective Study in Sarcoma Patients(ReTraSarc) | completed | — | 514 | University Medicine GreifswaldOTHER | 1 | Nov 15, 2021 | clinicaltrials |
| NCT03768076 | an Istitution Experience on Parosteal OsTeosarcoma | completed | — | 220 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT04906876 | A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas | withdrawn | Phase 2 | 0 | Brown UniversityOTHER | 1 | Jul 28, 2021 | clinicaltrials |
| NCT00525057 | Dalteparin in Preventing DVT in Participants With Cancer | completed | N/A | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT03468075 | Gemcitabine Plus Ascorbate for Sarcoma in Adults | terminated | Phase 2 | 10 | Mohammed Milhem, MBBSOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT02520128 | A Study of IMRT in Primary Bone and Soft Tissue Sarcoma(IMRiS) | completed | N/A | 191 | University College, LondonOTHER | 2 | Dec 2, 2020 | clinicaltrials |
| NCT02192333 | Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors | completed | N/A | 390 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 9, 2020 | clinicaltrials |
| NCT02301039 | SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas | completed | Phase 2 | 144 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Sep 29, 2020 | clinicaltrials |
| NCT01047878 | Genomic Analysis of Pediatric Bone Tumors | completed | — | 163 | Stanford UniversityOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT03968471 | Chemotherapy-induced Necrosis in Ewing Sarcoma | completed | — | 474 | Istituto Ortopedico RizzoliOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02199938 | Identification and Characterization of Molecular Markers in Musculoskeletal Tumors | terminated | — | 50 | Balgrist University HospitalOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02775799 | National Swiss Sarcoma Cohort Study(SwissSARCOS) | terminated | — | 50 | Balgrist University HospitalOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT00960063 | A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) | terminated | Phase 1 | 4 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 27, 2018 | clinicaltrials |
| NCT01553539 | Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | completed | Phase 2 | 20 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT00931931 | HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors | completed | Phase 1 | 18 | Timothy CripeOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT02443103 | Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis | terminated | N/A | 4 | Kathy MillerOTHER | 1 | Feb 13, 2018 | clinicaltrials |
| NCT01313884 | Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma | terminated | Phase 2 | 3 | Stanford UniversityOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT02982486 | A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | unknown | Phase 2 | 60 | Assaf-Harofeh Medical CenterOTHER_GOV | 0 | Nov 1, 2017 | clinicaltrials |
| NCT03002454 | Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo | terminated | Phase 3 | 4 | University of ManitobaOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT01541358 | Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer | terminated | N/A | 2 | Stanford UniversityOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT00674193 | Evaluating Dactinomycin and Vincristine in Young Patients With Cancer | completed | — | 158 | Children's Oncology GroupNETWORK | 3 | May 17, 2017 | clinicaltrials |
| NCT03106675 | MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases | unknown | N/A | 30 | Turku University HospitalOTHER_GOV | 0 | Apr 24, 2017 | clinicaltrials |
| NCT00450736 | Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | completed | Phase 1 | 3 | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT01163539 | Cyberknife Radiosurgery and Quality of Life | terminated | — | 15 | Stanford UniversityOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00720174 | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 17, 2016 | clinicaltrials |
| NCT01085565 | Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System | completed | Phase 2 | 50 | InSightecINDUSTRY | 1 | Mar 8, 2016 | clinicaltrials |
| NCT00474994 | Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas | completed | Phase 2 | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01674101 | Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy | completed | N/A | 20 | St. Jude Children's Research HospitalOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01374672 | Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma | completed | — | 20 | Children's Oncology GroupNETWORK | 1 | May 12, 2015 | clinicaltrials |
| NCT00538239 | Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)(SUCCEED) | completed | Phase 3 | 711 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT01795430 | Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00618813 | Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors | completed | N/A | 35 | Children's Oncology GroupNETWORK | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00516295 | Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma | completed | Phase 2 | 7 | National Cancer Institute (NCI)NIH | 1 | Sep 2, 2014 | clinicaltrials |
| NCT00002898 | Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 400 | Societe Internationale d'Oncologie PediatriqueOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00334854 | Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | unknown | Phase 3 | 250 | European Paediatric Soft Tissue Sarcoma Study GroupOTHER | 9 | Aug 12, 2013 | clinicaltrials |
| NCT00334984 | Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma | withdrawn | N/A | 0 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2013 | clinicaltrials |
| NCT00031915 | Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01830153 | RAD001 in Advanced Sarcoma | completed | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00160719 | HLA Sensitization Following Major Cortical Allograft Bone Procedures | completed | — | 10 | University of FloridaOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00160758 | Physical Characteristics of Retrieved Massive Allografts | completed | — | 18 | University of FloridaOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00632294 | Retrospective Study of the Biomechanical Properties of Large Allografts | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Aug 25, 2022source: clinicaltrials